We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
-4.29%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$1.92B
AUM Growth
-$64.5M
Cap. Flow
+$89.8M
Cap. Flow %
4.67%
Top 10 Hldgs %
14.65%
Holding
1,008
New
367
Increased
112
Reduced
107
Closed
328

Sector Composition

Rank Sector Weight
1 Healthcare 4.59%
2 Consumer Discretionary 2.4%
3 Energy 2.06%
4 Financials 1.79%
5 Technology 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REMX icon
626
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.95B
$126K 0.01%
3,333
MRNS
627
PUT
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$125K 0.01%
20,350
-78,450
-79% -$634K
MHK icon
628
Mohawk Industries
MHK
$7.5B
$124K 0.01%
1,000
OCUL icon
629
Ocular Therapeutix
OCUL
$1.79B
$122K 0.01%
+40,000
New +$179K
IMGN
630
DELISTED
Immunogen Inc
IMGN
$121K 0.01%
50,000
-30,000
-38% -$79.7K
CHGG icon
631
Chegg
CHGG
$110M
$120K 0.01%
4,000
-20,700
-84% -$821K
FOLD
632
DELISTED
Amicus Therapeutics
FOLD
$119K 0.01%
+15,000
New +$163K
HZNP
633
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$109K 0.01%
+4,000
New +$103K
CTRA
634
DELISTED
Coterra Energy
CTRA
$92K ﹤0.01%
+5,200
New +$99.7K
OVV icon
635
PUT
Ovintiv
OVV
$17.3B
$92K ﹤0.01%
4,000
ABEO icon
636
Abeona Therapeutics
ABEO
$366M
$91K ﹤0.01%
+1,600
New +$120K
NPTN
637
DELISTED
NEOPHOTONICS CORP
NPTN
$91K ﹤0.01%
15,000
+2,300
+18% +$12.9K
EB
638
PUT
DELISTED
Eventbrite
EB
$84K ﹤0.01%
+4,800
New +$84.2K
PAA icon
639
Plains All American Pipeline
PAA
$17.3B
$83K ﹤0.01%
4,000
+1,500
+60% +$33.9K
BIG
640
DELISTED
Big Lots, Inc.
BIG
$83K ﹤0.01%
3,400
MHK icon
641
CALL
Mohawk Industries
MHK
$7.5B
$75K ﹤0.01%
600
GT icon
642
Goodyear
GT
$2B
$72K ﹤0.01%
+5,000
New +$66.6K
MRNS
643
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$69K ﹤0.01%
11,250
PI icon
644
Impinj
PI
$4.62B
$68K ﹤0.01%
+2,200
New +$76.8K
FBRX icon
645
PUT
Forte Biosciences
FBRX
$1.57B
$66K ﹤0.01%
267
CPRX
646
DELISTED
Catalyst Pharmaceutical
CPRX
$64K ﹤0.01%
12,000
FBRX icon
647
Forte Biosciences
FBRX
$1.57B
$64K ﹤0.01%
256
-84
-25% -$127K
TISI icon
648
CALL
Team
TISI
$79.5M
$64K ﹤0.01%
360
HIBB
649
DELISTED
Hibbett, Inc. Common Stock
HIBB
$62K ﹤0.01%
2,700
-61,300
-96% -$1.12M
AGEN
650
CALL
Agenus
AGEN
$312M
$59K ﹤0.01%
1,146
-128
-10% -$6.85K

Similar funds

Caption Management's Q3 2019 Portfolio in Review

As of Q3 2019, Caption Management held 1,008 positions worth $1.92B, down 3.2% from $1.99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Caption Management deployed $89.8M of net new capital in Q3 2019, opening 367 new positions and adding to 112 existing holdings. Its largest new stake was PayPal: 215,000 shares worth $22.3M.

By sector, the portfolio is most concentrated in Healthcare at 4.6% of assets, up from 3% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Spark Therapeutics, Inc. Common Stock, an estimated $6.21M trimmed.

  • Caption Management's largest Q3 2019 buy was PayPal: 215,000 shares worth $22.3M.
  • Caption Management added most to Medicines Co in Q3 2019, an estimated $7.54M increase.
  • Caption Management's biggest Q3 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $6.21M.
  • Caption Management fully exited Upbound Group in Q3 2019, selling an estimated $8.44M.
  • Caption Management's ten largest holdings make up 15% of its $1.92B portfolio in Q3 2019.
  • Caption Management opened 367 new positions and closed 328 in Q3 2019.
  • Caption Management's portfolio value fell 3.2% quarter-over-quarter to $1.92B.

Based on Caption Management's 13F filing for Q3 2019, filed 14 Nov 2019.